Literature DB >> 18726893

ERK activation and nuclear signaling induced by the loss of cell/matrix adhesion stimulates anchorage-independent growth of ovarian cancer cells.

Adnan Al-Ayoubi1, Adel Tarcsafalvi, Hui Zheng, Wayne Sakati, Scott T Eblen.   

Abstract

Ovarian cancer metastasis involves the sloughing of epithelial cells from the ovary into the peritoneal cavity, where the cells can survive and proliferate in peritoneal ascites under anchorage-independent conditions. For normal epithelial cells and fibroblasts, cell adhesion to the extracellular matrix is required to prevent apoptosis and for proper activation and nuclear signaling of the ERK MAP kinase. The mechanisms of ERK regulation by adhesion have been determined by our lab and others. In this report, we elucidate a novel means of ERK regulation by cellular adhesion in ovarian cancer cells. We demonstrate that ERK and its activator MEK are robustly stimulated after cell detachment from a substratum in several ovarian cancer cell lines, but not a benign ovarian cell line, independent of serum and FAK or PAK activity. MEK and ERK activation was sustained for 48 h after detachment, while activation by serum or growth factors in adherent cells was transient. Re-attachment of suspended ovarian cells to fibronectin restored basal levels of MEK and ERK activity. ERK activity in suspended cells was dynamically controlled through an autocrine stimulatory pathway and prevalent phosphatase activity. Suspended cells demonstrated higher levels of ERK nuclear signaling to Elk1 compared to adherent cells. Inhibition of ERK activation with the MEK inhibitor U0126 had minor effects on adherent cell growth, but greatly decreased growth in soft agar. These data demonstrate a unique regulation of ERK by cellular adhesion and suggest a mechanism by which ERK may regulate anchorage-independent growth of metastatic ovarian cancer cells. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726893     DOI: 10.1002/jcb.21889

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  SPARCL1 suppresses the proliferation and migration of human ovarian cancer cells via the MEK/ERK signaling.

Authors:  Yan Ma; Yuan Xu; Li Li
Journal:  Exp Ther Med       Date:  2018-08-07       Impact factor: 2.447

2.  Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.

Authors:  Yan-Ling Chen; Jun-Jiao Song; Xiao-Chun Chen; Wei Xu; Qiang Zhi; Yun-Peng Liu; Hong-Zhi Xu; Jin-Shui Pan; Jian-Lin Ren; Bayasi Guleng
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

3.  Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.

Authors:  Katerina Kouvidi; Aikaterini Berdiaki; Dragana Nikitovic; Pavlos Katonis; Nikos Afratis; Vincent C Hascall; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

4.  Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion.

Authors:  Adnan M Al-Ayoubi; Hui Zheng; Yuying Liu; Tao Bai; Scott T Eblen
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

5.  Regulation of the microRNA 200b (miRNA-200b) by transcriptional regulators PEA3 and ELK-1 protein affects expression of Pin1 protein to control anoikis.

Authors:  Xusen Zhang; Bailin Zhang; Jidong Gao; Xiang Wang; Zhihua Liu
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

6.  E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway.

Authors:  Ling-ling Dong; Lian Liu; Chun-hong Ma; Ji-sheng Li; Chao Du; Shan Xu; Li-hui Han; Li Li; Xiu-wen Wang
Journal:  Acta Pharmacol Sin       Date:  2012-04-30       Impact factor: 6.150

Review 7.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

8.  Anchorage-independent growth of breast carcinoma cells is mediated by serum exosomes.

Authors:  Josiah Ochieng; Siddharth Pratap; Atanu K Khatua; Amos M Sakwe
Journal:  Exp Cell Res       Date:  2009-03-24       Impact factor: 3.905

9.  Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro.

Authors:  Irina S Smirnova; Steve Chang; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2009-10-19       Impact factor: 4.868

Review 10.  Comprehensive understanding of anchorage-independent survival and its implication in cancer metastasis.

Authors:  Zhong Deng; Huixue Wang; Jinlong Liu; Yuan Deng; Nu Zhang
Journal:  Cell Death Dis       Date:  2021-06-18       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.